Gritstone bio, Inc. (GRTS)
NASDAQ: GRTS · IEX Real-Time Price · USD
0.813
+0.049 (6.40%)
At close: Apr 26, 2024, 4:00 PM
0.830
+0.016 (2.03%)
After-hours: Apr 26, 2024, 6:01 PM EDT
Gritstone bio Market Cap
Gritstone bio has a market cap or net worth of $86.54 million as of April 26, 2024. Its market cap has decreased by -62.74% in one year.
Market Cap
86.54M
Enterprise Value
109.99M
1-Year Change
-62.74%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since September 28, 2018, Gritstone bio's market cap has decreased from $402.00M to $86.54M, a decrease of -78.47%. That is a compound annual growth rate of -24.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 74.90M | -6.02% |
| Apr 24, 2024 | 79.70M | 9.93% |
| Apr 23, 2024 | 72.50M | -0.96% |
| Apr 22, 2024 | 73.20M | 1.24% |
| Apr 19, 2024 | 72.30M | -0.96% |
| Apr 18, 2024 | 73.00M | -0.14% |
| Apr 17, 2024 | 73.10M | -3.43% |
| Apr 16, 2024 | 75.70M | 4.41% |
| Apr 15, 2024 | 72.50M | -12.12% |
| Apr 12, 2024 | 82.50M | -8.74% |
| Apr 11, 2024 | 90.40M | -2.59% |
| Apr 10, 2024 | 92.80M | -3.33% |
| Apr 9, 2024 | 96.00M | -3.03% |
| Apr 8, 2024 | 99.00M | 4.10% |
| Apr 5, 2024 | 95.10M | -6.31% |
| Apr 4, 2024 | 101.50M | -13.02% |
| Apr 3, 2024 | 116.70M | -0.85% |
| Apr 2, 2024 | 117.70M | -48.94% |
| Apr 1, 2024 | 230.50M | -8.53% |
| Mar 28, 2024 | 252.00M | -8.23% |
| Mar 27, 2024 | 274.60M | 8.11% |
| Mar 26, 2024 | 254.00M | -3.71% |
| Mar 25, 2024 | 263.80M | -1.82% |
| Mar 22, 2024 | 268.70M | -2.50% |
| Mar 21, 2024 | 275.60M | 2.95% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 83.53M |
| Reviva Pharmaceuticals Holdings | 83.20M |
| InflaRx | 81.85M |
| Oncolytics Biotech | 81.45M |
| TRACON Pharmaceuticals | 81.45M |
| Leap Therapeutics | 81.16M |
| Eton Pharmaceuticals | 80.04M |
| BrainsWay | 79.86M |